Infection Prevention and Antimicrobial Stewardship Program Collaboration During the COVID-19 Pandemic: a Window of Opportunity
- PMID: 34426728
- PMCID: PMC8374122
- DOI: 10.1007/s11908-021-00759-w
Infection Prevention and Antimicrobial Stewardship Program Collaboration During the COVID-19 Pandemic: a Window of Opportunity
Abstract
Purpose of review: We describe the similarities between antimicrobial stewardship programs (ASPs) and infection prevention programs (IPPs), and we discuss how these similarities lend themselves to synergy between programs. We also discuss how the COVID-19 pandemic has generated further opportunities for future collaborations that could benefit both programs.
Recent findings: The COVID-19 pandemic has created new needs, such as real-time data and access to personnel important to both programs, such as information technologists and infectious diseases specialists. It has also increased concerns about rising rates of antimicrobial resistance and healthcare-associated infections, both of which overlap significantly and are key focus areas for both ASPs and IPPs. These emergent issues have highlighted the need for enhanced program infrastructure and new team models. The shift towards telecommunication and telework has facilitated the creation of enhanced infrastructures for collaboration on activities ranging from data access and reporting to providing telehealth services to remote hospitals. These enhanced infrastructures can be leveraged in future collaborative efforts between ASPs and IPPs.
Summary: Collaboration between IPPs and ASPs can mitigate setbacks experienced by health systems during the current pandemic, enhance the performance of both programs in the post-pandemic era and increase their preparedness for future pandemic threats. As health systems plan for the post-pandemic era, they should invest in opportunities for synergy between ASPs and IPPs highlighted during the pandemic.
Keywords: Antimicrobial stewardship; COVID-19; Coronavirus disease 2019; Infection prevention; SARS-CoV-2.
© The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature 2021.
Conflict of interest statement
Conflict of InterestMariam Assi, Salma Abbas, Priya Nori, Michelle Doll, Emily Godbout, Gonzalo Bearman, and Michael P. Stevens declare that they have no conflicts of interest.
Figures
References
-
- Baur D, Gladstone BP, Burkert F, Carrara E, Foschi F, Döbele S, et al. Effect of antibiotic stewardship on the incidence of infection and colonisation with antibiotic-resistant bacteria and Clostridium difficile infection: a systematic review and meta-analysis. Lancet Infect Dis. 2017;17(9):990–1001. doi: 10.1016/s1473-3099(17)30325-0. - DOI - PubMed
-
- Antimicrobial Resistance Threats in the United States, 2013. Centers for Disease Control and Prevention. 2013 Available from: https://www.cdc.gov/drugresistance/threat-report-2013/pdf/ar-threats-201....
-
- Antimicrobial Resistance Threats in the United States, 2019. Centers for Disease Control and Prevention. 2019. Available from: https://www.cdc.gov/drugresistance/pdf/threats-report/2019-ar-threats-re....
-
- Core Elements of Hospital Antibiotic Stewardship Programs. Centers for Disease Control and Prevention. 2014. Available from: http://www.cdc.gov/getsmart/healthcare/pdfs/core-elements.pdf. - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous